To study the effect of drug VELLARUGU CHOORANAM on Gunman (peptic ulcer)
Phase 2
- Conditions
- Health Condition 1: null- ERIGUNMAM
- Registration Number
- CTRI/2018/04/012924
- Lead Sponsor
- Dr S Neelavathi MD siddha PhD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient with appropriate symptoms of burning pain in upper abdomen nausea waterbrash headache flatulence dizziness excessive sweating loss of body weight lack of food intake neuritic pain cough patient who are willing to sign consent form and undergo laboratory investigations
Exclusion Criteria
Pregnant and lactating women haemetemesis Malena pancreatitis inflammatory bowel disease recent malignancy or radiation therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The therapeutic efficacy of trial drug VELLARUGU CHOORANAM on ERIGUNMAMTimepoint: 30 days
- Secondary Outcome Measures
Name Time Method Evaluation of siddha diagnostic parametersTimepoint: 30 days